Revvity INC REVVITY ORD SHS/ US7140461093 /
| 2024-03-25 3:25:46 PM | Chg. - | Volume | Bid6:00:10 AM | Ask6:00:10 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 103.3900USD | - | 247 Turnover: 3,101.7000 |
-Bid Size: - | -Ask Size: - | 12.46 bill.USD | 0.28% | 18.14 |
GlobeNewswire
2021-05-18
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in the UK COVID-19 Human Challenge Study...
GlobeNewswire
2021-05-11
Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunol...
GlobeNewswire
2021-04-29
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell R...
